找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Antibacterials; Volume I Jed F. Fisher,Shahriar Mobashery,Marvin J. Miller Book 2018 Springer International Publishing AG, part of Springer

[復(fù)制鏈接]
11#
發(fā)表于 2025-3-23 11:55:53 | 只看該作者
Synergistic Antibiotic Combinations,n the two are combined. Because of increasing antibiotic resistance, and few new drugs to treat multidrug-resistant bacteria, combination therapy is often used in the clinical setting. Frequently, these combinations have demonstrated synergistic activity both in vitro and in animal models before bei
12#
發(fā)表于 2025-3-23 14:42:46 | 只看該作者
13#
發(fā)表于 2025-3-23 18:20:06 | 只看該作者
14#
發(fā)表于 2025-3-24 00:22:18 | 只看該作者
The Clinical Development of Antibacterial Drugs: A Guide for the Discovery Scientist,opment process. To meet this challenge, an innovator must have a basic understanding of those steps in this process that demand far more than knowledge of basic bench science. Perhaps the most difficult of these steps involves an understanding of regulatory and clinical development issues that only
15#
發(fā)表于 2025-3-24 03:57:06 | 只看該作者
Four Ways to Skin a Cat: Inhibition of Bacterial Topoisomerases Leading to the Clinic,st through Phase 2 clinical trials. Compounds from each of the four classes are not cross-resistant to one another as determined by analyses with laboratory and clinical resistant bacterial strains. Hence, they are defined herein as sharing a mode of action, in that they inhibit the same targets, bu
16#
發(fā)表于 2025-3-24 07:11:00 | 只看該作者
Book 2018hroughput screening, pharmacological in vitro and in vivo investigations, drug-receptor interactions on the molecular level, structure-activity relationships, drug absorption, distribution, metabolism, elimination, toxicology and pharmacogenomics. In general, special volumes are edited by well known
17#
發(fā)表于 2025-3-24 11:15:10 | 只看該作者
18#
發(fā)表于 2025-3-24 17:08:47 | 只看該作者
Philosophisch-psychologische Vorbemerkungen,lly with no clinical data to support their use. Because combination therapy will continue to be used in the absence of supportive clinical data, it will be important in the future to investigate mechanistic principles that may lead to predictive models for successful patient outcomes.
19#
發(fā)表于 2025-3-24 20:22:40 | 只看該作者
20#
發(fā)表于 2025-3-25 03:12:10 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-12 00:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
衡阳市| 富蕴县| 慈溪市| 五指山市| 新泰市| 江源县| 广西| 如皋市| 荔浦县| 西昌市| 武鸣县| 乐昌市| 临沂市| 遂宁市| 苍山县| 邯郸县| 沁阳市| 英山县| 中牟县| 额济纳旗| 常熟市| 福贡县| 台山市| 海淀区| 城口县| 乐昌市| 中宁县| 绥宁县| 镇巴县| 葫芦岛市| 班戈县| 运城市| 瑞昌市| 荔浦县| 兴义市| 巫溪县| 平利县| 城固县| 仁寿县| 周至县| 保山市|